Table 1 Baseline characteristics of study cohort.

From: Early detection of pulmonary exacerbations in children with Cystic Fibrosis by electronic home monitoring of symptoms and lung function

Characteristic

Total cohort (n = 49)

Age, mean (SD)

10.3 (3.6)

Male sex, N (%)

31 (63)

Homozygous dF508, N (%)

36 (74)

PEx in 2 years before inclusion, N (%)

23 (47)

Pseudomonas aeruginosa at inclusion*, N (%)

15(31)

ABPA at inclusion*, N (%)

2 (4)

BMI, median (IQR)

16.8 (16.0–18.1)

BMI-SDS, mean (SD)

0.14 (0.8)

FEV1% predicted value, mean (SD)

87.4 (18.1)

FVC % predicted value, mean (SD)

92.4 (16.4)

FEV1/FVC, mean (SD)

0.8 (0.1)

RV % predicted value, mean (SD)#

130.9 (42.7)

TLC % predicted value, mean (SD)#

101.1 (12.0)

Prophylactic antibiotics, N (%)

28 (57)

Inhalation corticosteroids, N (%)

16 (33)

  1. *Treated because of positive sputum culture. #Total n = 37 (12 children did not perform static lung function). Abbreviations: ABPA, Allergic Bronchopulmonary Aspergillosis; BMI, body mass index; FEV1, Forced Expiratory Volume in 1 second; FVC, Forced Vital Capacity; PEx, pulmonary exacerbation; RV, Residual Volume; SD, Standard deviation; TLC, Total Lung Capacity. All p > 0.05.
Back to article page